Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis

Journal of Neuroinflammation

Volumn 1, Issue , 2004, Pages

  Yao, Yuemang ^a   Chinnici, Cinzia ^a   Tang, Hanguan ^a   Trojanowski, John Q ^a   Lee, Virginia M Y ^a   Praticò, Domenico ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CURCUMIN; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG POTENTIATION; DRUG TARGETING; ENCEPHALITIS; FEMALE; HIPPOCAMPUS; LOW DRUG DOSE; MALE; MOUSE; NEOCORTEX; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; TRANSGENIC MOUSE;

EID: 18044392303     PISSN: 17422094     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-1-21     Document Type: Article

References (30)

1. Clark CM: Clinical manifestations and diagnostic evaluation of patients with Alzheimer's disease. In In: Neurodegenerative dementias: clinical; features and pathological mechanisms Edited by: Clark CM, Trojanowski JQ. New York: McGraw-Hill; 2000:95-114.
2. Praticò D, Trojanowski JQ: Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets? Neurobiol Aging 2000, 21:441-445.
3. Praticò D, Delanty N: Oxidative injury in diseases of the Central Nervous System: focus on Alzheimer's disease. Am J Med 2000, 1009:577-585.
4. Praticò D: Alzheimer's disease and oxygen radicals: new insights. Biochem Pharmacol 2002, 63:563-567.
5. Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G: Oxidative stress in Alzheimer's disease. Biochem Biophys Acta 2000, 1502:139-144.
6. Praticò D, Clark CM, Liun F, Lee VM-Y, Trojanowski JQ: Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer's disease. Arch Neurol 2002, 59:972-976.
7. Mecocci P: Oxidative stress in mild cognitive impairment and Alzheimer's disease: a continuum. J Alzhelmers Dis 2004, 6(2):159-163.
8. Pappolla MA, Chyan Y-J, Omar RA, Hsiao K, Perry G, Smith MA, Bozner P: Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer's disease. Am J Pathol 1998, 152:871-877.
9. Praticò D, Uryu K, Leight S, Trojanowski JQ, Lee VM-Y: Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 2001, 21: 4183-4187.
10. Matsuoka Y, Picciano M, La Francois J, Duff K: Fibrillary β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease. Neuroscience 2001, 104:609-613.
11. Stewart WF, Kawas C, Corrada M, Metter EJ: Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997, 48:626-632.
12. Neuroinflammation Working Group: Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21:383-421.
13. Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Hsiao Ashe K, Frautschy SA, Cole GM: Ibuprofen suppresses plaque pathology and inflammation in a mouse model of Alzheimer's disease. J Neurosci 2000, 20:5709-5714.
14. Jantzen PT, Connor KE, Dicarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN: Microglia activation and β-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J Neurosci 2002, 22:2246-2254.
15. Hsiao K, Chapman P, Nilsen S, Eckman C, Hargaya Y, Younkin S, Yan F, Cole G: Correlative memory deficits, Aβ elevation, and amyloid plaque in transgenic mice. Science 1996, 274:99-102.
16. Sun S, Yang H, Uryu U, Lee EB, Zhao L, Shineman D, Trojanowski JQ, Lee VM-Y, Praticò D: Modulation of NF-κ activity by indomethacin influences Aβ levels but not APP metabolism in a model of Alzheimer disease. Am J Pathol 2004 in press.
17. Sung S, Yao Y, Uryu K, Yang H, Lee VM-Y, Trojanowski JQ, Praticò D: Early vitamin E supplementation in young but not aged mice reduces Aβ levels and deposition in a transgenic model of Alzheimer's disease. FASEB J 2004, 18:323-325.
18. Stackman RW, Eckenstein F, Frei B, Kulhanek D, Nowlin J, Quinn JF: Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic ginkgo biloba treatment. Exp Neurol 2003, 184:510-520.
19. Kosik KS, Orecchio LD, Binder L, Trojanowski JQ, Lee VM-Y, Lee G: Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1988, 1:817-825.
20. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Hsiao Ashe K, Younkin SG: Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 2001, 21:372-381.
21. Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PLR, Siedlak SL, Tabaton M, Perry G: Amyloid β deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 1998, 70:2212-2215.
22. Drake J, Link CD, Butterfiled DA: Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caernorhabditis elegans. Neurobiol Aging 2003, 24:415-420.
23. Nunomura A, Perry G, Aliev G, Irai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohana S, Chiba S, Atwood CS, Petersen RB, Smith MA: Oxidative stress is the earliest event in Alzheimer's disease. J Neuropathol Exp Neurol 2001, 60:759-767.
24. Praticò D, Uryu K, Sung S, Trojanowski JQ, Lee VM-Y: Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J 2002, 16(9):1138-1140.
25. Li F, Calingasan NY, Yu F, Mauck WM, Toidze M, Almeida CG, Takahashi RH, Carlson GA, Beal MF, Lin MT, Gouras GK: Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J Neurochem 2004, 89:1308-1312.
26. Frautschy SA, Yang F, Irizarry M, Saido K, Cole GM: Microglia response to amyloid plaques in APPswe transgenic mice. Am J Pathol 1998, 152:307-317.
27. Benzing WC, Wujek JR, Ward EK, Shaffer D, Ashe KH, Younkin SG, Brunder KR: Evidence for glial-mediated inflammation in aged APPsw transgenic mice. Neurobiol Aging 2000, 20:581-589.
28. Gasparini L, Ongini E, Wenk G: Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action. J Neurochem 2004, 91:521-536.
29. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM: The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001, 21:8370-8377.
30. Kellof GJ, Criwell JA, Steele VE, Lubert RA, Malone WA, Boone CW, Kopelovich L, Hawk ET, Lieberman R, Lawrence JA, Ali I, Viner JL, Sigman CC: Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 2000, 130: 467-471.